Lacosamide in Refractory Mixed Pediatric Epilepsy: A Prospective Add-on Study

Lacosamide in Refractory Mixed Pediatric Epilepsy: A Prospective Add-on Study

Lacosamide is a new antiepileptic drug that is currently approved by the US Food and Drug Administration (FDA) for adults 17 years or older for partial-onset seizures. The authors reviewed 21 pediatric patients (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of child neurology 2012-04, Vol.27 (4), p.492-495
Hauptverfasser: Rastogi, Reena Gogia, Ng, Yu-Tze
Format: Artikel
Sprache:eng
Schlagworte:
Acetamides - therapeutic use
Adolescent
Anticonvulsants - therapeutic use
Antiepileptic agents
Child
Child, Preschool
Diet, Ketogenic - methods
Epilepsy
Epilepsy - classification
Epilepsy - diet therapy
Epilepsy - drug therapy
Female
Humans
Infant
Male
Pediatrics
Prospective Studies
Seizures
Treatment Outcome
Vagus Nerve Stimulation - methods
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lacosamide is a new antiepileptic drug that is currently approved by the US Food and Drug Administration (FDA) for adults 17 years or older for partial-onset seizures. The authors reviewed 21 pediatric patients (
ISSN:0883-0738
1708-8283
DOI:10.1177/0883073812436741